What is AccuRx?
AccuRx provides an intuitive platform designed to streamline communication between patients and healthcare professionals, thereby enhancing patient care within the UK's National Health Service (NHS). The software acts as a central hub, connecting diverse stakeholders across the healthcare ecosystem to improve the efficiency and effectiveness of patient management. Its widespread adoption is evident, with 98% of GP practices and 68% of NHS trusts currently utilizing its services. AccuRx extends its support across primary care, secondary care, community and mental health services, and integrated care initiatives, positioning itself as a critical digital health infrastructure provider.
How much funding has AccuRx raised?
AccuRx has raised a total of $38.1M across 1 funding round:
Series B
$38.1M
Series B (2021): $38.1M with participation from British Patient Capital, Lakestar, and Latitude VS
Key Investors in AccuRx
British Patient Capital
British Patient Capital, part of the British Business Bank, is a government-owned economic entity focused on providing financial support to UK businesses. They specialize in offering a range of finance solutions, including equity finance, to startups and growing companies aiming for investment and expansion.
Lakestar
Lakestar is a venture capital firm that partners with visionary tech entrepreneurs, investing from Seed to Growth stages in sectors like Deep Tech, Healthcare, and Fintech. They leverage their extensive European technology ecosystem connections to support ambitious founders.
What's next for AccuRx?
The recent major strategic investment signals AccuRx's transition into a scaling phase, likely focusing on expanding its service offerings and deepening its integration within the NHS. This capital infusion will probably be directed towards enhancing platform capabilities, potentially exploring new technological integrations such as AI for predictive patient management, and broadening its reach to encompass a wider array of healthcare providers. The company's strong market penetration suggests a future trajectory aimed at solidifying its position as the leading communication and patient management solution in the UK healthcare landscape, possibly eyeing further expansion into adjacent markets or specialized healthcare sectors.
See full AccuRx company page